What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 4 minute read Pharma Industry News pH-D Feminine Health initiates landmark FDA-cleared Phase 3 trial for boric acid suppositories in yeast infection treatment pH-D Feminine Health begins first FDA-cleared Phase 3 trial for boric acid suppositories, aiming for NDA approval and a breakthrough in recurrent yeast infection treatment. bySoujanya RaviAugust 12, 2025